Catalyst Event
Abbott Laboratories (ABT) · Earnings Release
From KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index (KUSDV100P)
7/16/2026, 12:00:00 AM
Abbott's Q2 2026 earnings release is scheduled for July 16, 2026. Analysts forecast EPS of $1.28. Medium importance estimated as earnings typically drive >5% price movement expected.
Korean Translation
2026년 7월 16일 애보트의 2026년 2분기 실적 발표 예정임. 분석가들은 EPS 1.28달러를 전망함. 실적 발표는 통상 5% 이상의 주가 변동을 유발하므로 중간 중요도로 예상됨.
Related Recent Events
Target Corp (TGT) · Earnings Release
Target's Q2 2026 earnings release is set for August 19, 2026; low importance is estimated as the date announcement itself typically has a market impact of less than 5%, scheduled.
8/19/2026, 12:00:00 AM
Bristol-Myers Squibb Co (BMY) · Other
The U.S. FDA set a PDUFA target action date for iberdomide on 2026-08-17; importance is Low as the setting of a PDUFA date is a procedural event with minor price impact.
8/17/2026, 12:00:00 AM
Chevron Corp (CVX) · Earnings Release
Q2 2026 earnings release is scheduled for August 7, 2026; analysts forecast a significant increase in earnings due to higher oil prices and full integration of Hess assets. Market impact is estimated at Medium (5%) as earnings are a primary driver of stock volatility, scheduled.
8/7/2026, 12:00:00 AM
EOG Resources Inc. (EOG) · Earnings Release
Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Cabot Corp (CBT) · Earnings Release
Q3 2026 earnings release and conference call scheduled.
8/3/2026, 12:00:00 AM
Exxon Mobil Corp (XOM) · Earnings Release
Q2 2026 earnings release is scheduled.
7/31/2026, 12:00:00 AM